Rheumatoid Arthritis in Primary Care 1: Management and Screening of Rheumatoid Arthritis in the Primary Care Setting


Rheumatoid Arthritis in Primary Care 1: Management and Screening of Rheumatoid Arthritis in the Primary Care Setting

Topic: Rheumatology
Relevant Terms: Rheumatoid Arthritis
Primary Audience: Primary care physicians and any healthcare professional interested in the management of rheumatoid arthritis
Launch Date: 17-Jan-12
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Improving the Management of Rheumatoid Arthritis: Addressing Unmet Needs for Primary Care...

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Diagnose patients with rheumatoid arthritis within the critical first 12 weeks in order to initiate therapy.
  2. Identify comorbid conditions associated with rheumatoid arthritis in order to more effectively manage patients.
  3. Develop comprehensive treatment plans for patients with rheumatoid arthritis taking into account the risk-benefit ratio.
  4. Manage patients with rheumatoid arthritis including assessing disease activity and treatment efficacy.


    Michael H. Weisman, MD
    Director, Division of Rheumatology
    Professor of Medicine
    Cedars-Sinai Medical Center
    Los Angeles, CA
    Paul P. Doghramji, MD, FAAFP
    Medical Director for Health Services at Ursinus College
    Family Physician, Collegeville Family Practice
    Collegeville, Pennsylvania
    Karen H. Costenbader, MD, MPH
    Associate Physician
    Division of Rheumatology, Immunology and Allergy
    Brigham and Women's Hospital
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts
    Sponsored by

    Supported by educational grants from Abbott Laboratories, Biogen Idec,
    Bristol-Myers Squibb, and Genentech, Inc.

    Program Overview
    Rheumatoid arthritis (RA) is a chronic inflammatory polyarthritis of uncertain etiology, which occurs in 0.8% to 1% of the population and is more common in women than men. Inflammation of the synovial membranes surrounding joints is characteristic of RA and is a result of the influx of immune cells induced by inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). This results in damage to surrounding tissues, especially cartilage and bone. Over time, bony erosions, deformities, and ultimately, joint destruction develop, accompanied by progressive pain and dysfunction.

    Target Audience
    This activity is designed to meet the needs of primary care physicians and other health care professionals who are interested in the management of patients with rheumatoid arthritis.
    Accreditation Statement
    Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Credit Designation
    Cedars-Sinai Medical Center designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Disclosure Policy Statement
    It is the policy of Cedars-Sinai Medical Center to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Cedars-Sinai Medical Center assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter's content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.

    While Cedars-Sinai Medical Center endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.
    When asked to report relevant financial relationships with commercial interests, faculty reported the following:

    Michael Weisman, MD:
    • Honoraria directly from commercial interest or their agent: Crescendo Bioscience
    • Royalties: Elsevier, Oxford University Press, UpToDate
    Paul P. Doghramji, MD:
    • Consulting Fee/Speakers Bureau: Cephalon, URL Pharma
    Karen H. Costenbader, MD:
    • Nothing to disclose
    The materials for this activity were peer reviewed by Dmitry Karayev, MD, Private Practice, West Hollywood, CA. Dr. Karayev has no relevant financial relationships to report.
    Instructions for Participating in This Activity and Obtaining CME Credit
    There are no fees for participating in and receiving CME credit for this online educational activity.
    The opinions or views expressed in this CME activity are those of the presenters and do not necessarily reflect the opinions or recommendations of Cedars-Sinai Medical Center, SciMed or the commercial supporter(s). Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product, device, or procedure mentioned.

    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 0.5 AMA PRA Category 1 Credit™. Statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

    COURSE FORMAT: Internet CME Activity
    Course Viewing Requirements
    Internet Explorer (v6 or greater), or Firefox

    Release Date: January 17, 2012
    Expiration Date: January 16, 2013
    Estimated Time To Complete: 30 minutes
    Cedars-Sinai Medical Center Privacy Policy

    Cedars-Sinai Medical Center Terms and Conditions

    © 2012 Cedars-Sinai Medical Center and SciMed